Legal & General Group
VXRT

Legal & General Group’s Vaxart VXRT Stock Holding History

Legal & General Group’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-12,785
Closed -$9.67K – 3524
2023
Q1 		$9.67K Hold
12,785
– – ﹤0.01% 3212
2022
Q4 		$12.3K Sell
12,785
-50,392
-80% -$71.2K ﹤0.01% 3236
2022
Q3 		$138K Buy
63,177
+1,449
+2% +$5K ﹤0.01% 2734
2022
Q2 		$216K Buy
61,728
+525
+0.9% +$1.96K ﹤0.01% 2600
2022
Q1 		$308K Buy
61,203
+1,607
+3% +$8.14K ﹤0.01% 2532
2021
Q4 		$373K Buy
59,596
+269
+0.5% +$1.84K ﹤0.01% 2507
2021
Q3 		$472K Buy
59,327
+23,943
+68% +$197K ﹤0.01% 2429
2021
Q2 		$264K Buy
35,384
+25,401
+254% +$177K ﹤0.01% 2471
2021
Q1 		$60K Sell
9,983
-385
-4% -$2.96K ﹤0.01% 2764
2020
Q4 		$60K Buy
10,368
+4,293
+71% +$27.3K ﹤0.01% 2754
2020
Q3 		$40K Sell
6,075
-1,027
-14% -$9.15K ﹤0.01% 2766
2020
Q2 		$63K Buy
+7,102
New +$20.4K ﹤0.01% 2666

Other funds holding VXRT

CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return

Legal & General Group's VXRT Position: Q2 2023 in Review

Legal & General Group sold out of Vaxart (VXRT) in Q2 2023, closing a stake of 12,785 shares — an estimated $9.67K sold.

Legal & General Group first reported a position in VXRT in Q2 2020 and held it in 12 quarters. The position peaked at $472K in Q3 2021. 111 funds tracked by Wall St. Rank hold VXRT as of Q2 2023.

  • Legal & General Group reported no remaining Vaxart position as of Q2 2023 after selling out during the quarter.
  • Legal & General Group sold 12,785 Vaxart shares in Q2 2023, an estimated $9.67K.
  • Legal & General Group first reported a position in Vaxart in Q2 2020 and held it in 12 quarters.
  • Legal & General Group's Vaxart position peaked at $472K in Q3 2021.
  • 111 funds tracked by Wall St. Rank held Vaxart as of Q2 2023.

Based on Legal & General Group's 13F filing for Q2 2023, filed 14 Aug 2023.